Caitlin Violanti, LMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 53 Center St, Angola, NY 14006 Phone: 716-435-5422 |
Lisa N Mann, LMHC, CASAC, MSED Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 8656 Delamater Rd Ste G, Angola, NY 14006 Phone: 716-817-0599 |
News Archive
Intarcia Therapeutics, Inc. presented today the results of a phase 2 clinical study of ITCA 650 (DUROSĀ® continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual Conference of the American Diabetes Association in Orlando, FL (June 25-29, 2010). Results of the phase 2 study demonstrated substantial reductions in HbA1c and body weight during the 12 weeks of treatment with ITCA 650 at both the 20 mcg/day and 40 mcg/day doses.
Cannasat Therapeutics Inc., a clinical stage pharmaceutical company developing products to treat neurological disorders such as neuropathic pain and schizophrenia, today announced its results for the six months ended June 30, 2009. Unless specified otherwise, all amounts are in Canadian dollars.
A multicenter study led by Christian Haass and Michael Ewers of Ludwig-Maximilians-Universitaet in Munich has identified a biomarker associated with the activation of an innate immune response to neural damage during early stages of Alzheimer's disease.
Life Technologies Corporation today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.
› Verified 8 days ago